Entering text into the input field will update the search result below

Baudax Bio regains compliance with Nasdaq's listing rules

Mar. 07, 2022 8:18 AM ETBaudax Bio, Inc. (BXRX)By: Preeti Singh, SA News Editor
  • Baudax Bio (NASDAQ:BXRX) has regained compliance with Nasdaq's minimum bid price requirement under Listing Rule 5550(a)(2).
  • Nasdaq staff made this determination of compliance after the company's bid price closed above $1.00/share for ten consecutive business days from Feb. 16, 2022 to Mar. 2, 2022.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.